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Summary
Background Conﬁ rmation of a diagnosis of tuberculosis in children (aged <15 years) is challenging; under-reporting 
can result even when children do present to health services. Direct incidence estimates are unavailable, and WHO 
estimates build on paediatric notiﬁ cations, with adjustment for incomplete surveillance by the same factor as adult 
notiﬁ cations. We aimed to estimate the incidence of infection and disease in children, the prevalence of infection, and 
household exposure in the 22 countries with a high burden of the disease.
Methods Within a mechanistic mathematical model, we combined estimates of adult tuberculosis prevalence in 2010, 
with aspects of the natural history of paediatric tuberculosis. In a household model, we estimated household exposure 
and infection. We accounted for the eﬀ ects of age, BCG vaccination, and HIV infection. Additionally, we tested 
sensitivity to key structural assumptions by repeating all analyses without variation in BCG eﬃ  cacy by latitude.
Findings The median number of children estimated to be sharing a household with an individual with infectious 
tuberculosis in 2010 was 15 319 701 (IQR 13 766 297–17 061 821). In 2010, the median number of Mycobacterium 
tuberculosis infections in children was 7 591 759 (5 800 053–9 969 780), and 650 977 children (424 871–983 118) developed 
disease. Cumulative exposure meant that the median number of children with latent infection in 2010 was 53 234 854 
(41 111 669–68 959 804). The model suggests that 35% (23–54) of paediatric cases of tuberculosis in the 15 countries 
reporting notiﬁ cations by age in 2010 were detected. India is predicted to account for 27% (22–33) of the total burden 
of paediatric tuberculosis in the 22 countries. The predicted proportion of tuberculosis burden in children for each 
country correlated with incidence, varying between 4% and 21%.
Interpretation Our model has shown that the incidence of paediatric tuberculosis is higher than the number of 
notiﬁ cations, particularly in young children. Estimates of current household exposure and cumulative infection 
suggest an enormous opportunity for preventive treatment.
Funding UNITAID and the US Agency for International Development.
Copyright © Dodd et al. Open Access article distributed under the terms of CC BY.
Introduction
Tuberculosis is largely a disease of poverty, and therefore 
children with the disease frequently live in poor 
communities with few health services.1 Social, logistic, 
and ﬁ nancial issues can mean that children are not 
brought for assessment after the development of 
symptoms, and even if they are assessed, a conﬁ rmed 
diagnosis can be challenging because of a low bacillary 
load and diﬃ  culties of specimen collection.2 Therefore, a 
diagnosis is often made presumptively on the basis of a 
combination of clinical symptoms, signs, and radiological 
ﬁ ndings. However, in regions where other diseases with 
overlapping features (eg, HIV, systemic viral or bacterial 
infections, parasitic infections, and bacterial, viral, or 
atypical pneumonia) are also endemic, the sensitivity and 
speciﬁ city of these diagnostic approaches are imperfect.3
Even children who are diagnosed and treated are often 
not recorded in registers or reported to national 
tuberculosis programmes,4 meaning that the number of 
cases is diﬃ  cult to establish directly. Childhood tubercu-
losis has been neglected by health programmers and 
academics, because children frequently have pauci-
bacillary disease and are not thought to be infectious; 
from a public health perspective, they are deemed not to 
constitute a high risk of disease propagation within a 
community.5 Additionally, the global community has not 
set paediatric-speciﬁ c targets for reduction of the disease 
burden. Because of the absence of clear paediatric 
targets, perceptions of low public health importance, 
and challenges in presentation, diagnosis, treatment, 
and reporting, estimates of disease burden have not 
been prioritised.
Nevertheless, interest in paediatric tuberculosis is 
increasing, and in 2012, WHO presented estimates of the 
global burden in children for the ﬁ rst time.6 WHO started 
with the number of childhood tuberculosis cases reported 
to the organisation (for countries in which data are 
disaggregated into paediatric and adult cases) and then 
combined this number with an estimate of paediatric 
notiﬁ cations for countries in which data are not 
disaggregated (calculated with the ratio between child 
and adult cases from the countries in which data are 
disaggregated). Because of the scarcity of evidence about 
how the gap between notiﬁ cations and underlying 
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disease incidence varies by age, this estimate of notiﬁ ed 
cases in children was then inﬂ ated to account for 
incomplete case detection with the global, all-ages case 
detection proportion of 66%, generating an estimate for 
the underlying tuberculosis incidence. This procedure 
yielded a global estimate of 490 000 tuberculosis cases 
per year (uncertainty interval 470 000–510 000) in children 
younger than 15 years, corresponding to 6% of the 
8·7 million estimated incident cases in 2011.6 Although 
WHO’s approach was straightforward and transparent, 
diﬃ  culties have been acknowledged with each step—ie, 
notiﬁ cations for children, extrapolations for non-
reporting countries, and especially the inﬂ ation to 
account for undetected cases.
With a more complete understanding of the burden of 
tuberculosis in children, the children who are developing 
the disease could be identiﬁ ed, which would allow 
programmes to target interventions where they are needed 
most and help with the rational planning of service and 
resource allocation. Identiﬁ cation of discrepancies 
between the number of expected cases and the number of 
treated cases would allow targeting of health systems that 
are not ﬁ nding, diagnosing, treating, or reporting appro-
priate numbers of child cases. From a public health 
perspective, children with tuberculosis represent recent 
transmission and can be judged as sentinel markers of 
disease transmission in the community and therefore as 
indicators of tuberculosis control.7 Finally, an under-
standing of the likely burden of disease is key for advocacy 
and market assessments, and would be essential for 
motivation of the research and development of new 
diagnostics, vaccines, and drugs adapted for the needs of 
children as well as adults.
In light of the diﬃ  culties with diagnosis and 
notiﬁ cation of childhood tuberculosis, we aimed to 
develop a mecha nistic mathematical model to estimate 
the number of cases indirectly in the 22 countries with a 
high burden of tuberculosis. These countries are reported 
to harbour 80% of the global burden.6 We estimated the 
incidence of infection and disease in children, the 
prevalence of infection, and household exposure. Because 
predictions are not based on childhood notiﬁ cations, this 
method is independent of existing approaches, and can be 
compared with reporting.
Methods
Study design
We used the same workﬂ ow for each of the 22 countries 
included (ﬁ gure 1). The age-stratiﬁ ed population 
determined the total number of children at risk in each 
country (the denominator). Because most demographic 
data were available for 2010, we used epidemiological 
data from this year as well. We calculated exposure and 
infection with two techniques: one was based on a 
community model and the other on a detailed model of 
household exposure. 
Community model
We combined WHO estimates of tuberculosis prevalence6 
with notiﬁ cation data for 2010, stratiﬁ ed by disease type 
(smear positive, smear negative, or extrapulmonary), to 
estimate the force of Mycobacterium tuberculosis infection 
in the 22 high-burden countries (HBCs). We modelled 
uncertainty in prevalence estimates with gamma 
distributions matched to the 95% ranges quoted for each 
country. We assumed a linear association between force 
of infection and tuberculosis prevalence, modelling the 
gradient by a Weibull distribution ﬁ tted to pooled data 
from two reviews8,9 in which the ratio between annual risk 
of infection and prevalence of smear-positive tuberculosis 
Figure 1: Overview of the modelling logic
Numbers at risk are fed through models of exposure and infection, and risks of progression to disease (modiﬁ ed by BCG vaccination and HIV)  to arrive at estimates of 
tuberculosis incidence in children. Diamonds represent data sources, squares represent numbers estimated at each stage, and stadiums represent modelling stages.
Numbers of
children at risk
Infection 
incidence
Model of exposure
Demographic
data
Input
Prevalence of
tuberculosis
Input
HIV infection
Changes
Changes
ChangesInput
Input
Household data
Data for annual
risk of tuberculosis 
infection
Latitude BCG vaccination
Probability of
progression to disease
Incident extrapulmonary 
tuberculosis by age
Incident pulmonary 
tuberculosis by age
Total incidence 
of tuberculosis 
in children
Articles
www.thelancet.com/lancetgh   Vol 2   August 2014 e455
was analysed. We obtained the number of children 
infected every year with M tuberculosis in each country by 
multiplying the predicted force of infection by estimated 
numbers of children in diﬀ erent age groups (0–1, 1–2, 
2–5, 5–10, and 10–15 years) according to UN population 
estimates.1 We computed infection prevalence with the 
survival function for escaping infection, assessed at the 
midpoints of the age groups.
Household model
As an alternative to modelling the risk of M tuberculosis 
infection, we estimated household exposure to infectious 
cases of tuberculosis for diﬀ erent age groups, ignoring 
exposure outside the household. We obtained 
Demographic and Health Survey data describing the 
composition of households by age and sex for 16 of the 
22 HBCs. We developed an in-silico representation of each 
population, and, for a speciﬁ c prevalence, we used the 
relevant country’s age and sex distribution of smear-
positive notiﬁ cations to distribute tuberculosis cases 
between individuals. We then computed the number of 
children in each age group in the same household as an 
individual of any age with tuberculosis, and repeated the 
process 10 000 times to obtain an estimate of the probability 
of household exposure. When household data for a country 
were not available, we imputed the association between 
tuberculosis prevalence and household exposure risk. We 
used the number of children cohabiting with an individual 
with tuberculosis to estimate the incidence of infection (via 
the household), modelling infection rates (based on 
contact studies10–12) with a log normal distribution and 
assuming smear-negative tuberculosis to be on average 
23% as infectious as smear-positive diseases.13,14
Progression to disease
Probabilities of progression from infection to disease in 
each age group were modelled with beta distributions on 
the basis of Marais and colleagues’ report,15 as were the 
probabilities of the ensuing disease being pulmonary or 
extra-pulmonary. We modelled BCG vaccination eﬃ  cacy in 
prevention of extra-pulmonary disease and the fraction of 
this protection eﬀ ective against pulmonary tuberculosis as 
beta distributions, on the basis of systematic reviews.8,16–18 
As suggested by Palmer and colleagues,19 we allowed a 
proportion of the eﬃ  cacy of BCG vaccination to vary with 
latitude (measured at the countries’ capital cities), with 
eﬃ  cacy at the equator 59% of that at the poles. We used 
WHO estimates of BCG coverage for each country. We 
accounted for the eﬀ ect of HIV infection on incidence by 
an incidence rate ratio, modelled as a log normal 
distribution, on the basis of a study of the eﬀ ect of HIV 
infection on risk of tuberculosis in children.20 HIV 
prevalence in those younger than 15 years was taken from 
data from the Joint United Nations Programme on HIV/
AIDS, and again we modelled uncertainty with gamma 
distributions and assumed prevalence to be zero where 
data were not available. We multiplied the estimates of the 
number of children with M tuberculosis infection in each 
age group by probabilities of progression, and then 
modiﬁ ed values by the eﬀ ects of BCG vaccination and HIV 
infection to arrive at estimates of incidence of paediatric 
tuberculosis by country, age group, and disease type.
Numerical methods
We constructed probability distributions representing 
uncertainty in estimated quantities with a Latin 
hypercube sample of size 50 000 from across all the 
distributions representing uncertainty in model 
parameters and input data. To assess the sensitivity to 
key structural assumptions, we repeated all analyses 
without variation in BCG eﬃ  cacy by latitude, and 
repeated the household analysis assuming a uniform 
distribution of tuberculosis cases by age and sex across 
adults. We did all computations in the R environment for 
statistical computing. Further details about the methods, 
including all parameter values, are in the appendix.
Role of the funding source
The funders of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to all 
the data in the study and had ﬁ nal responsibility for the 
decision to submit for publication. 
Results
Table 1 shows the model estimates for children aged 0–1, 
1–2, 2–5, 5–10, and 10–15 years. Tuberculosis exposure, 
infection, and disease was lower in under-5s than children 
aged 5–15 years. The most likely model prediction (the 
mode) is that about 500 000 cases of tuberculosis occurred 
in children younger than 15 years in the 22 HBCs in 2010 
(ﬁ gure 2). The median number of cases predicted was 
650 977 (IQR 424 871–983 118). The median number of 
children younger than 15 years estimated to be sharing a 
household with an individual with infectious tuberculosis 
in the 22 HBCs was 15 319 701 (13 766 297–17 061 821), and 
the median number of M tuberculosis infections occurring 
in children younger than 15 years in 2010 was 7 591 759 
(5 800 053–9 969 780). The cumulative incidence of 
infection yielded a median estimated number of children 
younger than 15 years with latent tuberculosis infection at 
the end of 2010 of 53 234 854 (41 111 669–68 959 804). The 
mode value for incidence of infection in the household 
was about 300 000 (ﬁ gure 2). The median number of 
household infections was 396 078 (IQR 271 905–565 304).
A uniform distribution of ages in the household model 
of exposure led to disease estimates that were 11% higher 
than the distribution based on adult age and sex 
notiﬁ cations (appendix). An assumption that the eﬃ  cacy 
of BCG vaccination did not wane towards the equator 
resulted in disease estimates that were 27% lower for all 
methods of estimating infection (appendix).
The proportion of the total incidence of paediatric 
tuberculosis in the 22 HBCs occurring in children with 
See Online for appendix
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HIV infection was estimated at 5·0% (IQR 2·4–10·1). 
However, in both South Africa and Zimbabwe, this 
proportion was predicted to be more than 25% 
(appendix). Tuberculosis incidence at younger ages 
(<5 years) was predicted to make up 58% (IQR 40–77) of 
the total, and 23% (13–36) of the disease in this age group 
was predicted to be extrapulmonary (appendix). In all 
children younger than 15 years, 14% (8–22%) of disease 
was estimated to be extrapulmonary.
Discrepancies between the number of reported cases 
and estimated incidence were heterogeneous between 
countries but under-reporting was more pronounced in 
the younger age group (ﬁ gure 3). India is predicted to 
account for 27% (22–33) of the total burden of paediatric 
tuberculosis in the 22 HBCs (ﬁ gure 4). The model suggests 
that 35% (IQR 23–54) of paediatric cases of tuberculosis in 
the 15 HBCs reporting notiﬁ cations by age in 2010 were 
detected, compared with 74% of all cases of tuberculosis in 
these countries (on the basis of WHO estimates). The 
predicted proportion of total tuberculosis burden occurring 
in children for each country ranged from 4% to 21% 
(ﬁ gure 5).
Discussion
Overall, although the uncertainty ranges were large, our 
model predicted that about 7·6 million children younger 
than 15 years in the 22 HBCs became infected with 
M tuberculosis in 2010, and roughly 650 000 developed 
tuberculosis (panel). We have estimated that about 
15 million children younger than 15 years in these 
countries were living in the same household as an adult 
with tuberculosis, and roughly 53 million children were 
estimated to be infected with M tuberculosis in 2010. 
These ﬁ gures are medians for the corresponding 
probability distributions. We chose medians as a Bayes 
estimator with a linear penalty in the error, and to allow 
natural reporting of uncertainty ranges.
As far as we are aware, we are the ﬁ rst to attempt to 
estimate the burden of childhood tuberculosis with a 
mechanistic model, using prevalence of tuberculosis in 
adults to estimate rates of infection and disease in children. 
We used an updated version of Styblo’s rule8,9 to relate 
tuberculosis prevalence to the incidence of infection, and 
used a model of household exposure and infection. We 
then incorporated evidence about age-related progression 
risks, BCG vaccination eﬃ  cacy, and the eﬀ ect of HIV. This 
strategy is complementary to other approaches in which 
paediatric notiﬁ cation data are used more directly, and 
synthesises a more complete picture of the epidemiology 
by modelling intermediate steps to disease. Because we 
modelled paediatric incidence starting from estimates of 
adult prevalence, predicted incidence in children can be 
compared with paediatric notiﬁ cations to identify potential 
shortfalls in reporting. Many aspects of the natural history 
of paediatric tuberculosis, and the data used as inputs for 
the model, have large uncertainties. These uncertainties 
are fairly reﬂ ected in the model outputs, and quantiﬁ cation 
of their relative contributions helps to identify areas in 
which precise understanding would most improve the 
accuracy of our approach. The approach lends itself to 
automation, which means that estimates can be updated 
on the basis of new data.
The 22 HBCs we assessed are estimated to have 80% of 
the global tuberculosis burden.6 Although the varying 
Children younger than 5 years Children aged 5–15 years
Number of children sharing household with an individual with tuberculosis* 5 354 128 (4 814 454–5 953 851) 9 969 007 (8 951 616–11 099 616)
Number of children infected with Mycobacterium tuberculosis in 2010† 2 645 968 (2 020 926–3 474 245) 4 946 152 (3 780 256–6 498 346)
Number of children infected with M tuberculosis at the end of 2010† 6 530 442 (4 993 555–8 518 986) 46 864 335 (36 110 021–60 525 588)
Number of children developing tuberculosis in 2010† 327 237 (205 206–494 575) 281 431 (134 237–526 014)
Data are median (IQR). *From household model. †From community model.
Table 1: Estimates of tuberculosis exposure, latent infection, and disease in children in 22 high-burden countries in 2010
Figure 2: Density estimates of the probability distribution of total incidence 
of paediatric tuberculosis for the 22 high-burden countries in 2010
The household model estimates infection through household exposure, and so 
only includes incidence of disease from this route of infection. The community 
model relates infection to overall tuberculosis prevalence in adults, and 
aggregates all routes of infection (household and community). The density 
estimates are based on binning the outputs of model runs to form a histogram 
that represents how likely diﬀ erent model estimates are in view of the 
uncertainty in the inputs.
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association between tuberculosis burden in adults and 
children by setting means these countries are likely to 
have a higher proportion of global paediatric tuberculosis, 
extrapolation of our approach would suggest a global 
burden that is up to 25% higher than our prediction for 
the 22 HBCs.
Our model has identiﬁ ed large populations that could 
beneﬁ t from preventive treatment, although not all 
children would be eligible. In view of the eﬃ  cacy of 
isoniazid preventive therapy,21,22 children who progress to 
disease after household exposure should be thought to 
have developed preventable tuberculosis; screening of 
individuals sharing a household with an adult who has 
been diagnosed with tuberculosis and treatment of child 
contacts would probably substantially reduce the 
numbers of children who develop the disease. The large 
numbers predicted by our model also represent the 
present and accumulated result of a failure to identify 
and treat adults with tuberculosis eﬀ ectively.
These estimates of child tuberculosis burden are 
somewhat higher than those in the 2012 WHO report,6 
similar to the notiﬁ cation-based estimates of Nelson 
and colleagues (although these estimates are from more 
than 10 years ago),23 and lower than the value of 1 million 
cases suggested by some commentators24,25 and the 
estimates of Jenkins and colleagues.26 The comparison 
of notiﬁ cations and model estimates suggests under-
reporting, most notably in children younger than 
5 years. However, some countries do have notiﬁ cation 
rates similar to estimated incidence. Further 
investigation is necessary to improve understanding of 
the reasons for the diﬀ erence between the number of 
estimated and notiﬁ ed cases in every country. In our 
model, India had by far the highest burden of paediatric 
tuberculosis, which is probably a result of its large size, 
demographic composition, and moderate tuberculosis 
prevalence.
The proportion of tuberculosis burden occurring in 
children has frequently been used to estimate probable 
paediatric burden where direct measurements do not 
exist.6 Local estimates for the proportion of tuberculosis 
burden in children vary widely, with some investigators 
reporting up to 39% of the burden in children.27 Donald28 
pointed out that increased proportions would be expected 
in countries where overall burden is highest, because of 
the correlation with younger-skewed demographics. He 
also noted that a high force of infection leads to a younger 
average age at infection, when risks of progression are 
highest.28 Our model reproduces this expected trend, 
with proportions predicted in a similar range to estimates 
by Nelson and colleagues.23 However, the countries with 
the largest contribution from HIV to tuberculosis 
incidence (South Africa and Zimbabwe) do not follow 
this pattern, reﬂ ecting the lower HIV prevalence in 
children than adults.
As with any model, our approach involved assumptions 
and has limitations. The limiting assumptions were 
Figure 3: Violin plot comparing model estimates of paediatric tuberculosis incidence in 2010, with numbers 
of cases in each age group reported to WHO by each country
Dots show the numbers of cases reported to WHO. The absence of a dot means paediatric notiﬁ cations were not 
reported by that country in 2010. The violins give a visual representation of the range and distribution of model 
estimates for each country on the basis of the community model. DR=Democratic Republic.
Figure 4: Numbers of new paediatric tuberculosis cases in 2010, by country
Estimates were calculated with the community model. Error bars show IQRs. 
DR=Democratic Republic.
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approximations in representation of HIV infection in 
children and uncertainties surrounding the nature, size, 
and variation of protection conferred by BCG vaccination. 
We did not have data for the age distribution of HIV 
infection in children, antiretroviral therapy coverage, or 
CD4 cell count in infected individuals; we treated HIV 
infection as one risk factor uniformly spread between 
children. Exposure to M tuberculosis and infection were 
not aﬀ ected by HIV in our model, but, in reality, household 
clustering of HIV means that children with HIV infection 
could be expected to have more exposure to tuberculosis 
than do children without HIV infection. Although the 
crudeness of the approach to HIV means that our 
conclusions for countries with high HIV prevalences 
should be treated with caution, the estimate that HIV 
contributes to 5% of the total incidence means that this 
issue is likely have little eﬀ ect on the overall estimate.
The eﬃ  cacy of BCG vaccination and the causes of 
recorded variability remain controversial,18 and could be 
aﬀ ected by the variation in vaccine strain used.29 In 
addition to incorporation of uncertain distributions that 
characterise the eﬃ  cacy of BCG vaccination against 
pulmonary and extrapulmonary tuberculosis, we 
considered structural model variants with unvarying 
BCG eﬃ  cacy by latitude. This approach might reﬂ ect an 
interpretation that perceived variation of BCG vaccination 
eﬃ  cacy is due to masking by heterologous immunity 
from non-tuberculous mycobacteria. Overall disease 
estimates were 27% lower under this assumption 
(infection estimates were unaﬀ ected).
Neither our model nor the studies on which estimates 
of progression were based diﬀ erentiated between 
M tuberculosis infection and a positive test of M tuberculosis 
sensitisation. Some children are anergic and can progress 
to tuberculosis without ever showing evidence of 
sensitisation. Risks of progression were based on reports 
from the early 20th century in white people and might not 
fully apply to populations that we assessed, which can 
diﬀ er systematically in factors aﬀ ecting risks of 
progression, such as host genetics, dominant 
M tuberculosis strain types, malnutrition, or vitamin D 
levels. We did not consider possible correlations between 
risk of exposure and infection, did not take account of any 
previous infection protecting against reinfection, and 
assumed that risks of progression were concentrated in 
the 1–2 years after infection. We did not consider 
subnational heterogeneity in transmission of tuberculosis, 
assuming that risks of infection were proportional to 
prevalence. Although some of this variation will average 
out for overall estimates, it could be important for speciﬁ c 
countries and country-level estimates, which should 
therefore be viewed with caution.
All model variants started from WHO estimates of adult 
tuberculosis prevalence, and therefore inherited their 
limitations. The most recent underlying demographic 
data were for 2010, and so we used tuberculosis, HIV, and 
BCG vaccination estimates for that year. We did not 
consider transmission of M tuberculosis from children, 
diﬀ erentiate between drug-resistant and drug-susceptible 
tuberculosis, or include preventive treatment.
Figure 5: Proportion of total tuberculosis burden that occurs in children and tuberculosis incidence in 2010 
for 22 high-burden countries
Proportions are based on mean model estimates from the community method. Incidences are based on WHO 
point estimates. DR=Democratic Republic.
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Panel: Research in context
Systematic review
We did a literature review of English language publications in PubMed, employing no 
date restrictions. Search terms included combinations of “mycobac*”, “tuberc*”, “tb”, 
“child*”, “ped*”, “paed*”, “burden”, “epidemiology”, “global”, “model”. We identiﬁ ed no 
previous studies which had used a mechanistic model to estimate the burden of 
tuberculosis in children. In our model, we used oﬃ  cial estimates from WHO, the UN, DHS 
data and UNAIDS, and combined them with several systematic reviews to inform 
transitions. The reviews by Bourdin Trunz and colleagues8 and Van Leth and colleagues9 
informed the association between tuberculosis prevalence and force of infection. The 
review by Fox and colleagues12 informed risk of infection after household exposure, and 
the review by Marais and colleagues15 informed the risk of progression to disease after 
infection. The eﬀ ect of BCG vaccination was informed by several reviews and the eﬀ ect 
of HIV was informed by the study from Hesseling and colleagues.20 
Interpretation
Our model predicts that about 650 000 children developed tuberculosis in 2010 in the 
22 countries with a high burden of the disorder. Because our estimates do not use 
paediatric notiﬁ cations as a starting point, the estimates can be compared with reported 
cases in each country to identify shortfalls. Our model also identiﬁ es vast numbers of 
children predicted to be exposed to tuberculosis every year and the even greater number 
of children who harbour latent tuberculosis infection.
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Our approach of taking infection via household exposure 
as a starting point provided an independent route to 
estimates, but only accounted for infections occurring in 
the household (probably a worse assumption in older age 
groups). Therefore, it is reassuring and revealing that 
estimates from the household model are lower than, but 
not radically diﬀ erent from, those from the community 
method, which implicitly includes all contexts of infection. 
In addition to those of our analysis, the household 
approach had its own limitations (appendix). We used 
notiﬁ cation data to inform the age and sex distribution of 
prevalent tuberculosis in each country. Notiﬁ cation data 
are subject to biases, even with restriction to smear-
positive cases. However, our sensitivity analysis with a 
model variant assuming an age-independent distribution 
of tuberculosis cases in adults increased disease estimates 
by 11%. Detailed comparable household data were not 
always for 2010 and not available at all for Russia or China, 
and our imputations in these cases might not have 
captured eﬀ ects due to any idiosyncrasies in these 
countries’ household compositions.
 In conclusion,  the burden of childhood tuberculosis 
that we have estimated through mathematical modelling 
represents a substantial fraction of the total global 
tuberculosis burden. The estimated incidence is higher 
than that of paediatric notiﬁ cations, with under-reporting 
most acute in the youngest ages. Our model also predicts 
high numbers of children with household exposure to 
M tuberculosis and infection, many of whom will go on to 
develop disease. Eﬀ ective household contact tracing and 
preventive therapy could have a substantial eﬀ ect on 
these preventable future cases.
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